검색어 : 통합검색[071.1]
총 1,216건 중 1,000건 출력
, 12/100 페이지
-
111
- Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects
- Yin, Wei; Mamashli, Fahimeh; Buhl, Derek L.; Khudyakov, Polyna; Volfson, Dmitri; Martenyi, Ferenc; Gevorkyan, Hakop; Rosen, Laura; Simen, Arthur A.; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Prothena Biosciences, South San Francisco, CA, USA; California Clinical Trials Medical Group, in affiliation with Parexel International, Glendale, CA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; (British journal of clinical pharmacology, v.88, 2022, pp.600-612)
-
112
- OC-071 Epithelial cytoplasmic hmgb1, epithelial nuclear runx3 and dynamic stromal lymphocytic phenotype are associated with oesophageal neoplastic progression
- Porter, RJ; Brice, DP; Murray, GI; Petty, RD; McLean, M; 1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen; 1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen; 1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen; 2Division of Cancer Research, Medical Research Institute, University of Dundee, Dundee, UK; 1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen; (Gut: journal of the British Society of Gastroenterology, v.66, 2017, pp.A38-A39)
-
113
- Lesbian Social Services: Research Issues Edited by Carol T. Tully. Binghamton, NY: Harrington Park Press, 1995. 90 pp. $9.95 paperback, ISBN 1-56023-071-1
- Peterson, K. J.; ; (Social work, v.42, 1997, pp.209-209)
-
114
- EP08.01-071 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Non-Squamous NSCLC
- Zhao, J.; Wu, J.; Cui, J.; Wang, L.; Sun, M.; Gao, B.; Ma, Z.; Liu, Y.; Wang, Z.; Li, X.; Li, H.; Zhang, J.; Sun, J.; Fei, C.; Wu, Y.-L.; ; (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, v.17, 2022, pp.S374)
-
115
- TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects
- Sako, Yuu; Kurimoto, Emi; Mandai, Takao; Suzuki, Atsushi; Tanaka, Maiko; Suzuki, Motohisa; Shimizu, Yuji; Yamada, Masami; Kimura, Haruhide; ; (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, v.44, 2019, pp.950-960)
-
116
- An Acetylcholine M<sub>1</sub> Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment : A Phase 2 Randomized Clinical Trial
- Shanbhag, Niraj M.; Padmanabhan, Jaya L.; Zhang, Zheng; Harel, Brian T.; Jia, Hongxia; Kangarloo, Tairmae; Yin, Wei; Dowling, Ariel V.; Laurenza, Antonio; Khudyakov, Polyna; Galinsky, Kevin; Latzman, Robert D.; Simuni, Tanya; Weintraub, Daniel; Horak, Fay B.; Lustig, Cindy; Maruff, Paul; Simen, Arthur A.; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Sage Therapeutics, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Takeda Development Center Americas, Inc, Cambridge, Massachusetts; Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelp; (JAMA neurology, v.82, 2025, pp.152)
-
117
- Euroanalysis VIII - analytical chemistry - September 5-11, 1993 Location: Edinburgh, UK. Contact: Miss P.E. Hutchinson, The Royal Society of Chemistry, Analytical Division, Burlington House, Piccadilly, London W1V 0BN, UK, Tel. (071) 437-8656, Telex 268001, Fax (071) 734-1227.
- ; ; (Clinica chimica acta, v.213, 1992, pp.126)
-
118
- Abstract A071: AG-120 (ivosidenib), a first-in-class mutant IDH1 inhibitor, promotes morphologic changes and upregulates liver-specific genes in IDH1 mutant cholangiocarcinoma
- Ishii, Yuko; Sigel, Carlie; Lowery, Maeve A.; Goyal, Lipika; Gliser, Camelia; Jiang, Liewen; Pandya, Susan; Wu, Bin; Choe, Sung; Deshpande, Vikram; ; (Molecular cancer therapeutics, v.17, 2018, pp.A071-A071)
-
119
- P2-071: PLOD2 and TTF1 expression as prognostic variables in selection for adjuvant treatment in early stage lung adenocarcinoma
- Davidson, Andrew; ; (Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, v.2, 2007, pp.S518)
-
120
- OP-071 THE ASSESSMENT OF THE RELATIONSHIP BETWEEN ARTERIAL BLOOD PRESSURE, AORTIC STIFFNESS AND SERUM ENDOTHELIN-1 LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
- Nar, G.; Yuksel, S.; Nar, R.; Meriç , M.; Soylu, K.; Zengin, H.; Gulel, O.; Demircan, S.; Yilmaz, Ö .; Sahin, M.; ; (International journal of cardiology, v.155, 2012, pp.S12-S13)
QUICK MENU
